Streetbeat News

Products Services

DXYZ

The Destiny Tech100 (NYSE:DXYZ) fund, which invests in private high-growth tech companies like SpaceX and OpenAI, has seen its stock price skyrocket by 558% to a market value of $644 million in just two weeks since its listing on March 26. Despite a high management fee of 2.5%, the fund's significant holdings in companies such as SpaceX (34.6%), Epic Games (4%), OpenAI (3.8%), and Chime (1.9%) offer investors unique exposure to the private tech sector.

Portfolio Pulse from Rounak Jain

April 06, 2024 | 3:18 am

TSLA

Tesla Inc (NASDAQ:TSLA) announced its vehicles have driven one billion miles using its Full Self-Driving (FSD) software, a significant increase from below 800 million miles at the end of 2023. CEO Elon Musk praised the Tesla AI team and projected reaching 10 billion FSD miles soon. The milestone follows Tesla's efforts to boost FSD adoption, including a 30-day free trial in the U.S. and in-car demonstrations of its driver-assist features. Musk emphasized the importance of vehicle autonomy to Tesla's market value.

Portfolio Pulse from Anan Ashraf

April 06, 2024 | 2:43 am

META

Meta Platforms Inc (NASDAQ:META) is expanding its manipulated media policy to include labels for AI-generated content such as photos and audio on Facebook, Instagram, and Threads. This decision follows recommendations from the company's Oversight Board to provide context for manipulated media rather than removing it. The new policy, which adds to the existing one that only covered videos, aims to introduce 'Made with AI' labels starting May 2024. Meta's approach is to add informational labels to AI-generated content unless it violates its policies, moving away from automatic removal based solely on its manipulated video policy.

Portfolio Pulse from Rounak Jain

April 06, 2024 | 1:45 am

AAPL

Wedbush analyst Dan Ives predicts Apple Inc. (AAPL) stock could soar to $250 with the unveiling of its AI strategy at WWDC 2024. Despite a 9% revenue decline from key supplier Foxconn and job cuts, Ives sees the AI strategy as a pivotal moment for Apple, potentially driving significant stock growth.

Portfolio Pulse from Ananya Gairola

April 06, 2024 | 1:19 am

AMRX

BHC

Bausch Health Companies Inc. (BHC) and its subsidiary, Salix Pharmaceuticals, have filed a patent lawsuit against Amneal Pharmaceuticals in New Jersey, concerning Amneal's attempt to market a generic version of XIFAXAN®. Amneal's ANDA claims that the patents for XIFAXAN® are unenforceable, invalid, or not infringed. This lawsuit triggers a 30-month stay on FDA approval for Amneal's product. Bausch Health has defended its XIFAXAN® intellectual property against other companies in the past, with some cases settled and one ongoing.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 10:28 pm

LINK

MA

V

The article discusses the hidden costs in DeFi, beyond upfront gas fees, that can impact investor returns, such as Impermanent Loss, Loss-Versus-Rebalancing, Slippage, and Maximal Extractable Value. It mentions traditional payment processors like Visa and Mastercard for comparison and highlights the dynamic nature of gas fees on platforms like Ethereum and Solana. It suggests ways to mitigate these costs, including understanding AMM models, researching platform strategies, and using tools like LlamaSwap, 1inch, Matcha, and Flashbots Protect. Newer oracle protocols like Pyth are also mentioned as innovative solutions.

Portfolio Pulse from Benzinga Contributor

April 05, 2024 | 9:22 pm

CLF

NEM

NUE

TX

Nucor Corporation introduces a weekly Consumer Spot Price for hot-rolled coil, aiming for transparent pricing. Cleveland-Cliffs praises a new DOE standard benefiting its steel production, potentially increasing demand. Newmont concludes a $20M support fund for pandemic-affected communities. Analysts adjust price targets for Newmont and Ternium, reflecting market expectations.

Portfolio Pulse from Austin DeNoce

April 05, 2024 | 8:41 pm

ELTX

Elicio Therapeutics, Inc. (NASDAQ:ELTX) announced it will present updated clinical and preclinical data at the AACR Annual Meeting. The data includes positive outcomes from the AMPLIFY-201 Phase 1 study of ELI-002, showing significant T cell responses in patients with mKRAS-driven cancers. Additionally, preclinical studies of ELI-007 and ELI-008 demonstrated substantial immune responses compared to conventional vaccines. ELTX plans to present initial ELI-002 7P clinical data in Q2 2024.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 8:34 pm

HOWL

Werewolf Therapeutics, Inc. (HOWL) presented preclinical results at AACR 2024 showing anti-tumor effects of WTX-518 and WTX-712, engineered to stimulate the immune system for cancer treatment. WTX-518 led to complete tumor regressions in models, while WTX-712 showed potent antitumor activity with a unique immune activation mechanism. The company aims to develop these as immunotherapies for refractory or immunologically unresponsive tumors.

Portfolio Pulse from Benzinga Newsdesk

April 05, 2024 | 8:32 pm

AMZN

GOOG

Decentralized Infrastructure Physical Networks (DePINs), leveraging blockchain technology, aim to disrupt tech monopolies by enabling decentralized access and management of internet, energy, and storage services. Highlighting the potential to democratize infrastructure, DePINs could offer solutions to underserved areas, incentivize participation through crypto tokens, and foster competition against centralized giants like Google and Amazon. Challenges include regulatory uncertainty and ensuring data privacy, but the initiative aligns with the broader Web3 vision of user control and data sovereignty.

Portfolio Pulse from Chris Were

April 05, 2024 | 8:29 pm